Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Role of Annexin A5 on Mitochondria-Dependent Apoptosis Induced by Tetramethoxystilbene in Human Breast Cancer Cells

  • Received : 2014.10.02
  • Accepted : 2014.10.15
  • Published : 2014.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

We have previously shown that 2,4,3',5'-tetramethoxystilbene (TMS), a trans-stilbene analogue, induces apoptosis in human cancer cells. However, the detailed mechanisms of mitochondria-dependent apoptosis induced by TMS are not fully understood. In the present study, the possible roles of annexin A5 in TMS-mediated apoptosis were investigated in MCF7 human breast cancer cells. Quantitative real-time PCR analysis and Western blot analysis showed that the expression of annexin A5 was strongly increased in TMS-treated cells. TMS caused a strong translocation of annexin A5 from cytosol into mitochondria. Confocal laser scanning microscopic analysis clearly showed that TMS induced translocation of annexin A5 into mitochondria. TMS increased the expression and oligomerization of voltage-dependent anion channel (VDAC) 1, which may promote mitochondria-dependent apoptosis through disruption of mitochondrial membrane potential. When cells were treated with TMS, the levels of Bax, and Bak as well as annexin A5 were strongly enhanced. Moreover, we found that the cytosolic release of apoptogenic factors such as cytochrome c, or apoptosis-inducing factor (AIF) in mitochondria was markedly increased. Annexin A5 depletion by siRNA led to decreased proapoptotic factors such as Bax, Bak, and annexin A5. Taken together, our results indicate that annexin A5 may play an important role in TMS-mediated mitochondrial apoptosis through the regulation of proapoptotic proteins and VDAC1 expression.

Keywords

References

  1. Chun, Y. J., Kim, S., Kim, D., Lee, S. K. and Guengerich, F. P. (2001) A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res. 61, 8164-8170.
  2. Chun, Y. J. and Kim, S. (2003) Discovery of cytochrome P450 1B1 inhibitors as new anti-cancer agents. Med. Res. Rev. 23, 657-668. https://doi.org/10.1002/med.10050
  3. Chun, Y. J., Lee, S. K. and Kim, M. Y. (2005) Modulation of human cytochrome P4501B1 expression by 2,4,3',5'-tetramethoxystilbene. Drug Metab. Dispos. 33, 1771-1776.
  4. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J. and Sutter, T. R. (1996) $17{\beta}$-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 93, 9776-9781. https://doi.org/10.1073/pnas.93.18.9776
  5. Jeong, J. J., Park, N., Kwon, Y. J., Ye, D. J., Moon, A. and Chun, Y. J. (2014) Role of annexin A5 in cisplatin-induced toxicity in renal cells: molecular mechanism of apoptosis. J. Biol. Chem. 289, 2469-2481. https://doi.org/10.1074/jbc.M113.450163
  6. Kim, S. W., Jung, H. K. and Kim, M. Y. (2008) Induction of p27kip1 by 2,4,3',5'-tetramethoxystilbene is regulated by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. Arch. Pharm. Res. 31, 1187-1194. https://doi.org/10.1007/s12272-001-1287-1
  7. Kwon, Y. J., Jung, J. J., Park, N. H., Ye, D. J., Kim, D., Moon, A. and Chun, Y. J. (2013) Annexin A5 as a new potential biomarker for cisplatin-induced toxicity in human kidney epithelial cells. Biomol. Ther. 21,190-195. https://doi.org/10.4062/biomolther.2013.026
  8. Liehr, J. G. (1997) Dual role of oestrogens as hormones and procarcinogens: tumor initiation by metabolic activation of oestrogens. Eur. J. Cancer Prev. 6, 3-10. https://doi.org/10.1097/00008469-199702000-00002
  9. Ravagnan, L., Roumier, T. and Kroemer, G. (2002) Mitochondria, the killer organelles and their weapons. J. Cell. Physiol. 192, 131-137. https://doi.org/10.1002/jcp.10111
  10. Rothhut, B., Dubois, T., Feliers, D., Russo-Marie, F. and Oudinet, J. P. (1995) Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur. J. Biochem. 232, 865-872. https://doi.org/10.1111/j.1432-1033.1995.tb20885.x
  11. Shimada, T., Gillam, E. M. J., Sutter, T. R., Strickland, P. T., Guengerich, F. P. and Yamazaki, H. (1997) Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab. Dispos. 25, 617-622.
  12. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P. and Sutter, T. R. (1996) Activation of chemically diversed procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56, 2979-2984.
  13. Shimada, T., Watanabe, J., Kawajiri, K., Sutter, T. R., Guengerich, F. P., Gillam, E. M. J. and Inoue, K. (1999) Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20,1607-1613. https://doi.org/10.1093/carcin/20.8.1607
  14. Tajeddine, N., Galluzzi, L., Kepp, O., Hangen, E., Morselli, E., Senovilla, L., Araujo, N., Pinna, G., Larochette, N., Zamzami, N., Modjtahedi, N., Harel-Bellan, A. and Kroemer, G. (2008) Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 27, 4221-4232 https://doi.org/10.1038/onc.2008.63
  15. van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B. and Reutelingsperger, C. P. (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1-9. https://doi.org/10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R

Cited by

  1. Effects of KRC-108 on the Aurora A activity and growth of colorectal cancer cells vol.461, pp.4, 2015, https://doi.org/10.1016/j.bbrc.2015.04.073
  2. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma vol.50, pp.5, 2017, https://doi.org/10.3892/ijo.2017.3942
  3. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling vol.10, pp.8, 2015, https://doi.org/10.1371/journal.pone.0134760
  4. CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation vol.11, pp.3, 2016, https://doi.org/10.1371/journal.pone.0151598
  5. Novel benzopyran derivatives and their therapeutic applications: a patent review (2009–2016) vol.27, pp.9, 2017, https://doi.org/10.1080/13543776.2017.1338687
  6. Deoxyarbutin displays antitumour activity against melanoma in vitro and in vivo through a p38-mediated mitochondria associated apoptotic pathway vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-05416-8
  7. Auranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer Cells vol.25, pp.2, 2017, https://doi.org/10.4062/biomolther.2016.223
  8. The Neuroprotective Role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5 2018, https://doi.org/10.1002/jcb.26170
  9. Identification of Biomarkers for Breast Cancer Using Databases vol.21, pp.4, 2016, https://doi.org/10.15430/JCP.2016.21.4.235
  10. Therapeutic Versatility of Resveratrol Derivatives vol.9, pp.11, 2017, https://doi.org/10.3390/nu9111188
  11. AnnexinA5 promote glioma cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway vol.138, pp.3, 2018, https://doi.org/10.1007/s11060-018-2818-4
  12. Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways vol.9, pp.6, 2018, https://doi.org/10.1038/s41419-018-0685-8
  13. Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells vol.23, pp.1, 2014, https://doi.org/10.3233/cbm-171040
  14. Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues vol.25, pp.4, 2014, https://doi.org/10.3390/molecules25040893